AFC-HD AMS Life Science Co., Ltd. ( (JP:2927) ) just unveiled an announcement.
AFC-HD AMS Life Science Co., Ltd. reported significant growth in its financial performance for the quarter ending November 2024, with net sales increasing by 20.7% year-over-year to 8,189 million yen. Operating profit also saw a substantial rise of 35.9%, indicating strong operational efficiency and market demand. The company’s improved financial metrics, including a 44.5% increase in profit attributable to owners, underscore its solid positioning in the life sciences sector and potential positive implications for stakeholders.
More about AFC-HD AMS Life Science Co., Ltd.
AFC-HD AMS Life Science Co., Ltd. is a company listed on the Tokyo Stock Exchange under the securities code 29270. It operates in the general business category, and its fiscal year ends on August 31. The company focuses on life sciences and operates primarily in Japan.
YTD Price Performance: 1.31%
Average Trading Volume: 18,449
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: Yen11.9B
For an in-depth examination of 2927 stock, go to TipRanks’ Stock Analysis page.